Pei Zhang

1PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 30, 2024
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China.

Jingxuan Wei, Kai Xu, Yingtao Lin

Pageof 1

Frequent Collaborators

1 joint publications

Jingxuan Wei

1 joint publications

Kai Xu

1 joint publications

Yingtao Lin

1 joint publications

Qiang Liu